Aloe vera and copaiba oleoresin-loaded chitosan films for wound dressings
Nenhuma Miniatura disponível
Data de publicação:
Título da Revista
ISSN da Revista
Título do Volume
É parte de
É parte de
É parte de
International Journal of Pharmaceutics
Chitosan films are commonly used for wound dressing, provided that this polymer has healing, mucoadhesiveness and antimicrobial properties. These properties can be further reinforced by the combination of chitosan with polysaccharides and glycoproteins present in aloe vera, together with copaiba oleoresin’s pharmacological activity attributed to sesquiterpenes. In this work, we developed chitosan films containing either aloe vera, copaiba oil or both, by casting technique, and evaluated their microbial permeation, antimicrobial activity, cytotoxicity, and in vivo healing potential in female adult rats. None of the developed chitosan films promoted microbial permeation, while the cytotoxicity in Balb/c 3 T3 clone A31 cell line revealed no toxicity of films produced with 2 % of chitosan and up to 1 % of aloe vera and copaiba oleoresin. Films obtained with either 0.5 % chitosan or 0.5 % copaiba oleoresin induced cell proliferation which anticipate their potential for closure of wound and for the healing process. The in vivo results confirmed that tested films (0.5 % copaiba-loaded chitosan film and 0.5 % aloe vera-loaded chitosan film) were superior to a commercial dressing film. For all tested groups, a fully formed epithelium was seen, while neoformation of vessels seemed to be greater in formulations-treated groups than those treated with the control. Our work confirms the added value of combining chitosan with aloe vera and copaiba oil in the healing process of wounds.
GENESI, BIANCA P.; BARBOSA, RAQUEL de M.; SEVERINO, PATRICIA; RODAS, ANDREA C.D.; YOSHIDA, CRISTIANA M.P.; MATHOR, MONICA B.; LOPES, PATRICIA S.; VISERAS, CESAR; SOUTO, ELIANA B.; SILVA, CLASSIUS F. da. Aloe vera and copaiba oleoresin-loaded chitosan films for wound dressings: microbial permeation, cytotoxicity, and in vivo proof of concept. International Journal of Pharmaceutics, v. 634, p. 1-12, 2023. DOI: 10.1016/j.ijpharm.2023.122648. Disponível em: http://repositorio.ipen.br/handle/123456789/33984. Acesso em: 28 Feb 2024.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.